nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—ABCB1—peripheral nervous system neoplasm	0.254	1	CbGaD
Gemcitabine—ABCC10—Vincristine—peripheral nervous system neoplasm	0.119	0.29	CbGbCtD
Gemcitabine—ABCC10—Etoposide—peripheral nervous system neoplasm	0.109	0.265	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.0741	0.181	CbGbCtD
Gemcitabine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0259	0.0632	CbGbCtD
Gemcitabine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0259	0.0632	CbGbCtD
Gemcitabine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0179	0.0438	CbGbCtD
Gemcitabine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.011	0.027	CbGbCtD
Gemcitabine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0103	0.0252	CbGbCtD
Gemcitabine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0101	0.0247	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00691	0.0169	CbGbCtD
Gemcitabine—Lamivudine—NME1—peripheral nervous system neoplasm	0.00494	0.931	CrCbGaD
Gemcitabine—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000591	0.107	CbGdCrCtD
Gemcitabine—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000591	0.107	CbGdCrCtD
Gemcitabine—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000448	0.0814	CbGdCrCtD
Gemcitabine—RRM2—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000435	0.0791	CbGdCrCtD
Gemcitabine—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000413	0.0751	CbGdCrCtD
Gemcitabine—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000413	0.0751	CbGdCrCtD
Gemcitabine—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000413	0.0751	CbGdCrCtD
Gemcitabine—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000413	0.0751	CbGdCrCtD
Gemcitabine—POLA1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000411	0.0748	CbGdCrCtD
Gemcitabine—Lamivudine—ABCB1—peripheral nervous system neoplasm	0.000364	0.0686	CrCbGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000336	0.00497	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000335	0.00495	CbGpPWpGaD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000335	0.00495	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000322	0.00476	CbGpPWpGaD
Gemcitabine—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.0569	CbGdCrCtD
Gemcitabine—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.0569	CbGdCrCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000306	0.00453	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000302	0.00447	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000301	0.00446	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—CDKN2A—peripheral nervous system neoplasm	0.000292	0.00431	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000287	0.00424	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GNS—peripheral nervous system neoplasm	0.000284	0.0042	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000281	0.00415	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000276	0.00408	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000272	0.00403	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NME1—peripheral nervous system neoplasm	0.000272	0.00403	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—COX2—peripheral nervous system neoplasm	0.000262	0.00388	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00025	0.00369	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000243	0.00359	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00024	0.00355	CbGpPWpGaD
Gemcitabine—RRM1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000236	0.00349	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000225	0.00332	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000224	0.00332	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000223	0.0033	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00021	0.0031	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000205	0.00303	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—MYC—peripheral nervous system neoplasm	0.000198	0.00292	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000198	0.00292	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000196	0.0029	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000195	0.00288	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000189	0.0028	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000188	0.00278	CbGpPWpGaD
Gemcitabine—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000186	0.0338	CbGdCrCtD
Gemcitabine—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000186	0.0337	CbGdCrCtD
Gemcitabine—RRM1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000184	0.00272	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000183	0.00271	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000181	0.00268	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000181	0.00267	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000178	0.00264	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000177	0.00262	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GNS—peripheral nervous system neoplasm	0.000176	0.0026	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000176	0.00259	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000173	0.00255	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000172	0.00255	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00017	0.00252	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000169	0.0025	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000169	0.00249	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000168	0.00249	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NME1—peripheral nervous system neoplasm	0.000168	0.00249	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000165	0.00244	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—peripheral nervous system neoplasm	0.000162	0.0024	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000162	0.0024	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—COX2—peripheral nervous system neoplasm	0.000162	0.0024	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00016	0.00237	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000159	0.00235	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000158	0.00234	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000158	0.00234	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000155	0.0023	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000154	0.00228	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000152	0.00224	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000151	0.00224	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000151	0.00223	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.00015	0.00222	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000149	0.0022	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000149	0.0022	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000147	0.00218	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000147	0.00217	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000145	0.00215	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000145	0.00214	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000144	0.00213	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000142	0.00209	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000141	0.00209	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00014	0.00207	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000139	0.00205	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000139	0.00205	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000137	0.00202	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—TH—peripheral nervous system neoplasm	0.000137	0.00202	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000136	0.00201	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000135	0.002	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000134	0.00199	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000134	0.00198	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000133	0.00197	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000133	0.00197	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GNS—peripheral nervous system neoplasm	0.000133	0.00197	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000133	0.00197	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.00013	0.00192	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000129	0.0019	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000129	0.0019	CbGpPWpGaD
Gemcitabine—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000129	0.0234	CbGdCrCtD
Gemcitabine—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000128	0.0232	CbGdCrCtD
Gemcitabine—RRM1—Metabolism—NME1—peripheral nervous system neoplasm	0.000128	0.00189	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000127	0.00188	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—MYC—peripheral nervous system neoplasm	0.000127	0.00188	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000127	0.00188	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000126	0.00187	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—BIRC5—peripheral nervous system neoplasm	0.000125	0.00184	CbGpPWpGaD
Gemcitabine—POLE—S Phase—MYC—peripheral nervous system neoplasm	0.000123	0.00182	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—COX2—peripheral nervous system neoplasm	0.000123	0.00182	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.00012	0.00177	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.00012	0.00177	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000119	0.00176	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000119	0.00176	CbGpPWpGaD
Gemcitabine—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.0216	CbGdCrCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000116	0.00171	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000115	0.0017	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000115	0.0017	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000114	0.00169	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000114	0.00169	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000112	0.00165	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000111	0.00164	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00011	0.00162	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNS—peripheral nervous system neoplasm	0.00011	0.00162	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000109	0.00162	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNS—peripheral nervous system neoplasm	0.000109	0.00161	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000106	0.00157	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NME1—peripheral nervous system neoplasm	0.000105	0.00155	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NME1—peripheral nervous system neoplasm	0.000104	0.00154	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000102	0.00152	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNS—peripheral nervous system neoplasm	0.000102	0.00151	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000102	0.00151	CbGpPWpGaD
Gemcitabine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000102	0.000396	CcSEcCtD
Gemcitabine—Rash—Topotecan—peripheral nervous system neoplasm	0.000102	0.000396	CcSEcCtD
Gemcitabine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000102	0.000395	CcSEcCtD
Gemcitabine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000102	0.000395	CcSEcCtD
Gemcitabine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000394	CcSEcCtD
Gemcitabine—Cough—Etoposide—peripheral nervous system neoplasm	0.000101	0.000394	CcSEcCtD
Gemcitabine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000393	CcSEcCtD
Gemcitabine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000393	CcSEcCtD
Gemcitabine—Headache—Topotecan—peripheral nervous system neoplasm	0.000101	0.000393	CcSEcCtD
Gemcitabine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000101	0.000392	CcSEcCtD
Gemcitabine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000101	0.000392	CcSEcCtD
Gemcitabine—RRM2—Metabolism—COX2—peripheral nervous system neoplasm	0.000101	0.0015	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000101	0.000392	CcSEcCtD
Gemcitabine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000101	0.000392	CcSEcCtD
Gemcitabine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000101	0.000392	CcSEcCtD
Gemcitabine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000101	0.000392	CcSEcCtD
Gemcitabine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000101	0.000391	CcSEcCtD
Gemcitabine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000101	0.00039	CcSEcCtD
Gemcitabine—POLD1—Metabolism—COX2—peripheral nervous system neoplasm	0.000101	0.00149	CbGpPWpGaD
Gemcitabine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0001	0.00039	CcSEcCtD
Gemcitabine—Headache—Tretinoin—peripheral nervous system neoplasm	0.0001	0.00039	CcSEcCtD
Gemcitabine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.0001	0.000389	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.0001	0.00148	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.000389	CcSEcCtD
Gemcitabine—Pain—Vincristine—peripheral nervous system neoplasm	0.0001	0.000389	CcSEcCtD
Gemcitabine—Constipation—Vincristine—peripheral nervous system neoplasm	0.0001	0.000389	CcSEcCtD
Gemcitabine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000388	CcSEcCtD
Gemcitabine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	9.99e-05	0.000388	CcSEcCtD
Gemcitabine—Rash—Melphalan—peripheral nervous system neoplasm	9.98e-05	0.000387	CcSEcCtD
Gemcitabine—Dermatitis—Melphalan—peripheral nervous system neoplasm	9.97e-05	0.000387	CcSEcCtD
Gemcitabine—TYMS—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.93e-05	0.00147	CbGpPWpGaD
Gemcitabine—Chest pain—Etoposide—peripheral nervous system neoplasm	9.9e-05	0.000384	CcSEcCtD
Gemcitabine—Anorexia—Cisplatin—peripheral nervous system neoplasm	9.87e-05	0.000383	CcSEcCtD
Gemcitabine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.000382	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	9.83e-05	0.000381	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	9.82e-05	0.00145	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NME1—peripheral nervous system neoplasm	9.82e-05	0.00145	CbGpPWpGaD
Gemcitabine—Discomfort—Etoposide—peripheral nervous system neoplasm	9.78e-05	0.000379	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000378	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000378	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	9.71e-05	0.00144	CbGpPWpGaD
Gemcitabine—Hypotension—Cisplatin—peripheral nervous system neoplasm	9.68e-05	0.000376	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000375	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	9.65e-05	0.00143	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—MYC—peripheral nervous system neoplasm	9.65e-05	0.00143	CbGpPWpGaD
Gemcitabine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	9.61e-05	0.000373	CcSEcCtD
Gemcitabine—Nausea—Topotecan—peripheral nervous system neoplasm	9.6e-05	0.000373	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	9.54e-05	0.00037	CcSEcCtD
Gemcitabine—Nausea—Tretinoin—peripheral nervous system neoplasm	9.53e-05	0.00037	CcSEcCtD
Gemcitabine—Nausea—Isotretinoin—peripheral nervous system neoplasm	9.53e-05	0.00037	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	9.5e-05	0.0014	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	9.49e-05	0.000368	CcSEcCtD
Gemcitabine—DCK—Metabolism—COX2—peripheral nervous system neoplasm	9.45e-05	0.0014	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	9.44e-05	0.000366	CcSEcCtD
Gemcitabine—Infection—Etoposide—peripheral nervous system neoplasm	9.43e-05	0.000366	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	9.41e-05	0.000365	CcSEcCtD
Gemcitabine—Nausea—Melphalan—peripheral nervous system neoplasm	9.4e-05	0.000365	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000364	CcSEcCtD
Gemcitabine—Influenza—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000363	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	9.32e-05	0.00138	CbGpPWpGaD
Gemcitabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.3e-05	0.000361	CcSEcCtD
Gemcitabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	9.29e-05	0.00036	CcSEcCtD
Gemcitabine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.26e-05	0.000359	CcSEcCtD
Gemcitabine—TYMS—G1/S Transition—MYC—peripheral nervous system neoplasm	9.25e-05	0.00137	CbGpPWpGaD
Gemcitabine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.000359	CcSEcCtD
Gemcitabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.23e-05	0.000358	CcSEcCtD
Gemcitabine—Skin disorder—Etoposide—peripheral nervous system neoplasm	9.22e-05	0.000358	CcSEcCtD
Gemcitabine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.17e-05	0.000356	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—AURKA—peripheral nervous system neoplasm	9.16e-05	0.00135	CbGpPWpGaD
Gemcitabine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000354	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	9.1e-05	0.00134	CbGpPWpGaD
Gemcitabine—Anorexia—Etoposide—peripheral nervous system neoplasm	9.04e-05	0.000351	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	9.02e-05	0.00035	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.02e-05	0.00035	CcSEcCtD
Gemcitabine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	9e-05	0.000349	CcSEcCtD
Gemcitabine—CDA—Metabolism—BCHE—peripheral nervous system neoplasm	8.99e-05	0.00133	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.99e-05	0.00133	CbGpPWpGaD
Gemcitabine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.97e-05	0.000348	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	8.94e-05	0.000347	CcSEcCtD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—BIRC5—peripheral nervous system neoplasm	8.88e-05	0.00131	CbGpPWpGaD
Gemcitabine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.000345	CcSEcCtD
Gemcitabine—Hypotension—Etoposide—peripheral nervous system neoplasm	8.87e-05	0.000344	CcSEcCtD
Gemcitabine—Pain—Cisplatin—peripheral nervous system neoplasm	8.86e-05	0.000344	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000343	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—AURKA—peripheral nervous system neoplasm	8.78e-05	0.0013	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—peripheral nervous system neoplasm	8.76e-05	0.0013	CbGpPWpGaD
Gemcitabine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000339	CcSEcCtD
Gemcitabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.72e-05	0.000338	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.7e-05	0.00129	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—BIRC5—peripheral nervous system neoplasm	8.69e-05	0.00128	CbGpPWpGaD
Gemcitabine—Influenza—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000336	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	8.63e-05	0.00128	CbGpPWpGaD
Gemcitabine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.6e-05	0.000334	CcSEcCtD
Gemcitabine—CDA—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.57e-05	0.00127	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.53e-05	0.000331	CcSEcCtD
Gemcitabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.52e-05	0.000331	CcSEcCtD
Gemcitabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.46e-05	0.000328	CcSEcCtD
Gemcitabine—CDA—Metabolism—TH—peripheral nervous system neoplasm	8.45e-05	0.00125	CbGpPWpGaD
Gemcitabine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	8.44e-05	0.000327	CcSEcCtD
Gemcitabine—Somnolence—Etoposide—peripheral nervous system neoplasm	8.44e-05	0.000327	CcSEcCtD
Gemcitabine—Asthenia—Vincristine—peripheral nervous system neoplasm	8.4e-05	0.000326	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000325	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—BIRC5—peripheral nervous system neoplasm	8.34e-05	0.00123	CbGpPWpGaD
Gemcitabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.34e-05	0.000323	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	8.33e-05	0.00123	CbGpPWpGaD
Gemcitabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.32e-05	0.000323	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000321	CcSEcCtD
Gemcitabine—Rash—Dactinomycin—peripheral nervous system neoplasm	8.27e-05	0.000321	CcSEcCtD
Gemcitabine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.25e-05	0.00032	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.000319	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000318	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	8.2e-05	0.00121	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.19e-05	0.000318	CcSEcCtD
Gemcitabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.19e-05	0.000318	CcSEcCtD
Gemcitabine—Fatigue—Etoposide—peripheral nervous system neoplasm	8.18e-05	0.000317	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000317	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	8.14e-05	0.0012	CbGpPWpGaD
Gemcitabine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000315	CcSEcCtD
Gemcitabine—Pain—Etoposide—peripheral nervous system neoplasm	8.11e-05	0.000315	CcSEcCtD
Gemcitabine—Constipation—Etoposide—peripheral nervous system neoplasm	8.11e-05	0.000315	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000314	CcSEcCtD
Gemcitabine—RRM1—Metabolism—ENO2—peripheral nervous system neoplasm	8.06e-05	0.00119	CbGpPWpGaD
Gemcitabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.01e-05	0.000311	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.00031	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000309	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.89e-05	0.00117	CbGpPWpGaD
Gemcitabine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000306	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—CHEK2—peripheral nervous system neoplasm	7.85e-05	0.00116	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.82e-05	0.000303	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.81e-05	0.000303	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	7.79e-05	0.00115	CbGpPWpGaD
Gemcitabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.79e-05	0.000302	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000302	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000301	CcSEcCtD
Gemcitabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.73e-05	0.0003	CcSEcCtD
Gemcitabine—Rash—Alitretinoin—peripheral nervous system neoplasm	7.66e-05	0.000297	CcSEcCtD
Gemcitabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.66e-05	0.000297	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000297	CcSEcCtD
Gemcitabine—Headache—Alitretinoin—peripheral nervous system neoplasm	7.62e-05	0.000295	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.59e-05	0.00112	CbGpPWpGaD
Gemcitabine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000294	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000293	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.56e-05	0.00112	CbGpPWpGaD
Gemcitabine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000292	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000292	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000291	CcSEcCtD
Gemcitabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000291	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.00029	CcSEcCtD
Gemcitabine—Vomiting—Vincristine—peripheral nervous system neoplasm	7.45e-05	0.000289	CcSEcCtD
Gemcitabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.43e-05	0.000288	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000288	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000287	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000287	CcSEcCtD
Gemcitabine—Rash—Vincristine—peripheral nervous system neoplasm	7.39e-05	0.000287	CcSEcCtD
Gemcitabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.38e-05	0.000286	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000286	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000285	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000285	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000285	CcSEcCtD
Gemcitabine—Headache—Vincristine—peripheral nervous system neoplasm	7.34e-05	0.000285	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000283	CcSEcCtD
Gemcitabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.22e-05	0.00028	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000279	CcSEcCtD
Gemcitabine—TYMS—Metabolism—GNS—peripheral nervous system neoplasm	7.18e-05	0.00106	CbGpPWpGaD
Gemcitabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.09e-05	0.000275	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.000275	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.00027	CcSEcCtD
Gemcitabine—Nausea—Vincristine—peripheral nervous system neoplasm	6.96e-05	0.00027	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.00027	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000269	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000269	CcSEcCtD
Gemcitabine—CDA—Metabolism—GNAS—peripheral nervous system neoplasm	6.9e-05	0.00102	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NME1—peripheral nervous system neoplasm	6.88e-05	0.00102	CbGpPWpGaD
Gemcitabine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.88e-05	0.000267	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000265	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000265	CcSEcCtD
Gemcitabine—RRM1—Metabolism—BCHE—peripheral nervous system neoplasm	6.81e-05	0.00101	CbGpPWpGaD
Gemcitabine—Asthenia—Etoposide—peripheral nervous system neoplasm	6.81e-05	0.000264	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000264	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000264	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000263	CcSEcCtD
Gemcitabine—CDA—Metabolism—ABCB1—peripheral nervous system neoplasm	6.77e-05	0.001	CbGpPWpGaD
Gemcitabine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000262	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000262	CcSEcCtD
Gemcitabine—Chills—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000261	CcSEcCtD
Gemcitabine—Pruritus—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.00026	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000259	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	6.64e-05	0.000982	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO2—peripheral nervous system neoplasm	6.64e-05	0.000982	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—COX2—peripheral nervous system neoplasm	6.63e-05	0.00098	CbGpPWpGaD
Gemcitabine—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000257	CcSEcCtD
Gemcitabine—POLD1—Metabolism—ENO2—peripheral nervous system neoplasm	6.6e-05	0.000976	CbGpPWpGaD
Gemcitabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.59e-05	0.000256	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	0.000254	CcSEcCtD
Gemcitabine—Rash—Cisplatin—peripheral nervous system neoplasm	6.53e-05	0.000253	CcSEcCtD
Gemcitabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.52e-05	0.000253	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000253	CcSEcCtD
Gemcitabine—RRM1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.5e-05	0.000961	CbGpPWpGaD
Gemcitabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.49e-05	0.000252	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	6.44e-05	0.000952	CbGpPWpGaD
Gemcitabine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000249	CcSEcCtD
Gemcitabine—RRM1—Metabolism—TH—peripheral nervous system neoplasm	6.4e-05	0.000947	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	6.4e-05	0.000946	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	6.37e-05	0.000941	CbGpPWpGaD
Gemcitabine—Back pain—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000245	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000244	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000243	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000242	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000241	CcSEcCtD
Gemcitabine—DCK—Metabolism—ENO2—peripheral nervous system neoplasm	6.2e-05	0.000917	CbGpPWpGaD
Gemcitabine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.00024	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	6.18e-05	0.000914	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.16e-05	0.000911	CbGpPWpGaD
Gemcitabine—Nausea—Cisplatin—peripheral nervous system neoplasm	6.15e-05	0.000239	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000238	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000235	CcSEcCtD
Gemcitabine—Vomiting—Etoposide—peripheral nervous system neoplasm	6.03e-05	0.000234	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000234	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.02e-05	0.000234	CcSEcCtD
Gemcitabine—Rash—Etoposide—peripheral nervous system neoplasm	5.98e-05	0.000232	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.98e-05	0.000232	CcSEcCtD
Gemcitabine—Headache—Etoposide—peripheral nervous system neoplasm	5.94e-05	0.000231	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	5.94e-05	0.000878	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.91e-05	0.000873	CbGpPWpGaD
Gemcitabine—Malaise—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000228	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000226	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000226	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	5.76e-05	0.000851	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	5.72e-05	0.000846	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BIRC5—peripheral nervous system neoplasm	5.69e-05	0.000841	CbGpPWpGaD
Gemcitabine—Cough—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000221	CcSEcCtD
Gemcitabine—Nausea—Etoposide—peripheral nervous system neoplasm	5.64e-05	0.000219	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000218	CcSEcCtD
Gemcitabine—RRM2—Metabolism—BCHE—peripheral nervous system neoplasm	5.61e-05	0.000829	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	5.6e-05	0.000827	CbGpPWpGaD
Gemcitabine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000217	CcSEcCtD
Gemcitabine—POLD1—Metabolism—BCHE—peripheral nervous system neoplasm	5.58e-05	0.000824	CbGpPWpGaD
Gemcitabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.57e-05	0.000216	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000215	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000215	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000215	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	5.53e-05	0.000817	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000214	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000213	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000211	CcSEcCtD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.41e-05	0.0008	CbGpPWpGaD
Gemcitabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000209	CcSEcCtD
Gemcitabine—RRM2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.35e-05	0.000791	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.32e-05	0.000786	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000206	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000206	CcSEcCtD
Gemcitabine—Infection—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000205	CcSEcCtD
Gemcitabine—RRM2—Metabolism—TH—peripheral nervous system neoplasm	5.27e-05	0.00078	CbGpPWpGaD
Gemcitabine—Cough—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000204	CcSEcCtD
Gemcitabine—POLD1—Metabolism—TH—peripheral nervous system neoplasm	5.24e-05	0.000775	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—BCHE—peripheral nervous system neoplasm	5.24e-05	0.000775	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GNAS—peripheral nervous system neoplasm	5.23e-05	0.000773	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000202	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000202	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000202	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.0002	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.14e-05	0.0002	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000199	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000199	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000199	CcSEcCtD
Gemcitabine—RRM1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.13e-05	0.000759	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	5.1e-05	0.000754	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000198	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000197	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000197	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.06e-05	0.000748	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC2A1—peripheral nervous system neoplasm	5e-05	0.000739	CbGpPWpGaD
Gemcitabine—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000193	CcSEcCtD
Gemcitabine—DCK—Metabolism—TH—peripheral nervous system neoplasm	4.93e-05	0.000729	CbGpPWpGaD
Gemcitabine—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000191	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000191	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.00019	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.85e-05	0.000717	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000188	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000187	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000187	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000187	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000185	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000185	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000185	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000184	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.73e-05	0.000699	CbGpPWpGaD
Gemcitabine—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000183	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000182	CcSEcCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	4.67e-05	0.000691	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.66e-05	0.000688	CbGpPWpGaD
Gemcitabine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000179	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000178	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000178	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000178	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000176	CcSEcCtD
Gemcitabine—Pain—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000176	CcSEcCtD
Gemcitabine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.54e-05	0.000671	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000174	CcSEcCtD
Gemcitabine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000173	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000171	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	4.4e-05	0.000651	CbGpPWpGaD
Gemcitabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.00017	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.00017	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.00017	CcSEcCtD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.37e-05	0.000645	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	4.36e-05	0.000645	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO2—peripheral nervous system neoplasm	4.35e-05	0.000643	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	4.34e-05	0.000641	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNAS—peripheral nervous system neoplasm	4.31e-05	0.000637	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNAS—peripheral nervous system neoplasm	4.28e-05	0.000633	CbGpPWpGaD
Gemcitabine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000166	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.27e-05	0.000632	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000165	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000165	CcSEcCtD
Gemcitabine—RRM2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.22e-05	0.000625	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	4.22e-05	0.000624	CbGpPWpGaD
Gemcitabine—Pain—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000163	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000163	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000163	CcSEcCtD
Gemcitabine—POLD1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.2e-05	0.000621	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	4.19e-05	0.000619	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.1e-05	0.000605	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.06e-05	0.000157	CcSEcCtD
Gemcitabine—DCK—Metabolism—GNAS—peripheral nervous system neoplasm	4.02e-05	0.000595	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—peripheral nervous system neoplasm	3.95e-05	0.000584	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	3.94e-05	0.000582	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—peripheral nervous system neoplasm	3.9e-05	0.000577	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000151	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—MYC—peripheral nervous system neoplasm	3.88e-05	0.000573	CbGpPWpGaD
Gemcitabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000148	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	3.77e-05	0.000558	CbGpPWpGaD
Gemcitabine—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000146	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—MYC—peripheral nervous system neoplasm	3.74e-05	0.000554	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BCHE—peripheral nervous system neoplasm	3.68e-05	0.000543	CbGpPWpGaD
Gemcitabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.000141	CcSEcCtD
Gemcitabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000137	CcSEcCtD
Gemcitabine—TYMS—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.51e-05	0.000518	CbGpPWpGaD
Gemcitabine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000135	CcSEcCtD
Gemcitabine—TYMS—Metabolism—TH—peripheral nervous system neoplasm	3.46e-05	0.000511	CbGpPWpGaD
Gemcitabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000131	CcSEcCtD
Gemcitabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000131	CcSEcCtD
Gemcitabine—Rash—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.00013	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.00013	CcSEcCtD
Gemcitabine—Headache—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000129	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—TP53—peripheral nervous system neoplasm	3.2e-05	0.000474	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—peripheral nervous system neoplasm	3.18e-05	0.000471	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000123	CcSEcCtD
Gemcitabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000121	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.00012	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.00012	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.00012	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—TP53—peripheral nervous system neoplasm	3.07e-05	0.000455	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.06e-05	0.000453	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—peripheral nervous system neoplasm	3.01e-05	0.000446	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	2.98e-05	0.000441	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.96e-05	0.000437	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000113	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	2.86e-05	0.000423	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNAS—peripheral nervous system neoplasm	2.82e-05	0.000417	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—peripheral nervous system neoplasm	2.77e-05	0.000409	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—peripheral nervous system neoplasm	2.67e-05	0.000394	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.57e-05	0.00038	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—peripheral nervous system neoplasm	2.56e-05	0.000378	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.33e-05	0.000345	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.31e-05	0.000342	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.22e-05	0.000328	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—peripheral nervous system neoplasm	2.19e-05	0.000324	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.12e-05	0.000314	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—peripheral nervous system neoplasm	2.1e-05	0.00031	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.04e-05	0.000302	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—peripheral nervous system neoplasm	1.86e-05	0.000275	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.86e-05	0.000275	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.82e-05	0.000269	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.5e-05	0.000221	CbGpPWpGaD
Gemcitabine—POLE—trigeminal ganglion—peripheral nervous system neoplasm	1.42e-05	0.0935	CbGeAlD
Gemcitabine—RRM1—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000209	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.34e-05	0.000198	CbGpPWpGaD
Gemcitabine—CMPK1—brainstem—peripheral nervous system neoplasm	1.34e-05	0.0883	CbGeAlD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000187	CbGpPWpGaD
Gemcitabine—POLA1—trigeminal ganglion—peripheral nervous system neoplasm	1.22e-05	0.0806	CbGeAlD
Gemcitabine—RRM2—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000172	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000171	CbGpPWpGaD
Gemcitabine—POLA1—parotid gland—peripheral nervous system neoplasm	1.15e-05	0.076	CbGeAlD
Gemcitabine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.13e-05	0.000168	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000161	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.00016	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.07e-05	0.000158	CbGpPWpGaD
Gemcitabine—RRM1—trigeminal ganglion—peripheral nervous system neoplasm	9.7e-06	0.0639	CbGeAlD
Gemcitabine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.71e-06	0.000129	CbGpPWpGaD
Gemcitabine—POLD1—cerebellum—peripheral nervous system neoplasm	8.27e-06	0.0545	CbGeAlD
Gemcitabine—SLC29A1—trigeminal ganglion—peripheral nervous system neoplasm	7.88e-06	0.052	CbGeAlD
Gemcitabine—TYMS—Metabolism—AKT1—peripheral nervous system neoplasm	7.62e-06	0.000113	CbGpPWpGaD
Gemcitabine—DCK—trigeminal ganglion—peripheral nervous system neoplasm	7.53e-06	0.0497	CbGeAlD
Gemcitabine—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	7.18e-06	0.0473	CbGeAlD
Gemcitabine—DCK—parotid gland—peripheral nervous system neoplasm	7.1e-06	0.0468	CbGeAlD
Gemcitabine—SLC29A2—cerebellum—peripheral nervous system neoplasm	6.94e-06	0.0458	CbGeAlD
Gemcitabine—ABCC10—parotid gland—peripheral nervous system neoplasm	6.77e-06	0.0446	CbGeAlD
Gemcitabine—CMPK1—cerebellum—peripheral nervous system neoplasm	6.6e-06	0.0435	CbGeAlD
Gemcitabine—POLE—cerebellum—peripheral nervous system neoplasm	6.18e-06	0.0408	CbGeAlD
Gemcitabine—POLA1—cerebellum—peripheral nervous system neoplasm	5.33e-06	0.0352	CbGeAlD
Gemcitabine—RRM1—cerebellum—peripheral nervous system neoplasm	4.23e-06	0.0279	CbGeAlD
Gemcitabine—TYMS—cerebellum—peripheral nervous system neoplasm	3.84e-06	0.0253	CbGeAlD
Gemcitabine—SLC29A1—cerebellum—peripheral nervous system neoplasm	3.44e-06	0.0227	CbGeAlD
Gemcitabine—DCK—cerebellum—peripheral nervous system neoplasm	3.29e-06	0.0217	CbGeAlD
Gemcitabine—ABCC10—cerebellum—peripheral nervous system neoplasm	3.13e-06	0.0206	CbGeAlD
Gemcitabine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.35e-06	3.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	2.07e-06	0.0137	CbGeAlD
Gemcitabine—ABCB1—cerebellum—peripheral nervous system neoplasm	9.04e-07	0.00596	CbGeAlD
